Double-blind placebo-controlled comparative study for the efficacy of treatment on the patient with NERD [gastro oesophageal reflux] between omeprasole versus omeprasole plus mosapride citrate

Trial Profile

Double-blind placebo-controlled comparative study for the efficacy of treatment on the patient with NERD [gastro oesophageal reflux] between omeprasole versus omeprasole plus mosapride citrate

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Dec 2010

At a glance

  • Drugs Mosapride (Primary) ; Omeprazole
  • Indications Gastro-oesophageal reflux
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Nov 2009 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 04 Jun 2009 Results have been presented at Digestive Disease Week 2009.
    • 14 Jan 2008 The expected completion date for this trial is now 1 Dec 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top